Washington, USA——Recently, Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort EP") obtained FDA (Food and Drug Administration) approval in U.S.A. for its independently researched & developed EasyFinder™ Fixed Curve Diagnostic Catheter. This product is the first mapping catheter to get FDA approval for MicroPort EP.
EasyFinder™ Fixed Curve Diagnostic Catheter is composed of a catheter body and a connecting cable. It can be used in combination with a multichannel EP recording system for electrophysiological study of the heart in medical institutions.
EasyFinder™ Fixed Curve Diagnostic Catheter has been certified by FDA and entered into American market for sale, which will further promote the internationalization process of the company's products, bring positive impact on the promotion of the company's products in overseas markets, and enhance the company's brand awareness overseas.
In the future, MicroPort EP will continue to invest in technology R&D, product innovation, to provide more perfect products and professional services, offering comprehensive solutions for diagnosis and therapy of EP interventions for doctors and patients worldwide.